Navigation Links
Immune Targeting Systems and WCCT Global Announce a New Influenza A H1N1 Virus to Support the Experimental Human Viral Challenge Model
Date:8/18/2014

ion and other standard containment provisions to accommodate this valuable research model and ensure the safety and comfort of the volunteers and staff. 

Benjamin Chen, PhD, CEO of Immune Targeting Systems said, "We are very excited that WCCT Global has taken over the ownership of this important clinical research tool and are confident that they will use the virus to help support the development of new vaccines and antiviral drugs".  Kenneth Kim, MD, CEO of WCCT Global said, " The capability to carry out the experimental influenza challenge model in conjunction with our deep-seated expertise in anti-viral drug development will surely be of great interest to our sponsors. This new capability combined with our Full Service Global capabilities, specialized influenza project teams, and deep scientific knowledge allows WCCTG to manage vaccine and antiviral development programs from First in Man through NDA submission."

More about Immune Targeting Systems

Immune targeting Systems, Ltd develops T-cell vaccines to highly mutated viruses and to cancers. The company's lead product  Flunisyn™ vaccine has been shown in three clinical studies to stimulate the production of T-cells that recognise and destroy influenza-infected cells. Flunisyn™  is a pan-influenza A vaccine applicable to multiple influenza strains without the need to be re-manufactured for each influenza season or pandemic outbreak.  The Company is also advancing the development of two other product candidates: a therapeutic Hepatitis B vaccine for chronic hepatitis B and a cancer vaccine for solid tumours. ITS is supported by Novartis Venture fund, Truffle Capital, HealthCap, Esperante Ventures and SME wholesale Finance.

More about WCCT Global

WCCT Global is a multi-site, full service pharmaceutical contract res
'/>"/>

SOURCE WCCT Global
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
2. Novimmune Reports Successful Completion of Phase I trial for NI-0101
3. Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
4. UMD Researcher Helps Arm the Immune System to Fight Cancer
5. Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
6. BHI Elects MedImmunes Reg Seeto, M.D. to Board of Directors
7. Global Autoimmune Disease Diagnostics Market
8. NW Bio Responds To Shareholder Inquiries Following Immune Therapy Sectors Recent Market Decline
9. High Cost of Biologics and Novel Oral Agents to Treat Immune Diseases Limits Patient Access
10. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
11. Unilife Announces Supply Agreement with MedImmune for Wearable Injectable Drug Delivery Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Neuraltus Pharmaceuticals, Inc. ... Phase 2 clinical program of NP001 for the treatment ... disease) are being highlighted today in an oral ... Research Group , being held in Bloomington, ... post hoc  analysis, administration of a high dose of ...
(Date:9/17/2014)... and MILL VALLEY, Calif. ... Sarcoma Alliance today announced a partnership in the ... will sponsor the Sarcoma Alliance Suzanne Renee Leider ... program offers financial assistance to reimburse sarcoma patients ... opinion from a sarcoma specialist. Scientific literature reinforces ...
(Date:9/17/2014)... Sept. 17, 2014  Trovagene, Inc., (NASDAQ:   TROV) ... Alberto Bardelli , Ph.D., has joined the Company,s ... to identify mutations in the kinase genes that are ... is at the Department of Oncology, Torino Medical School, ... . "Alberto,s work in cancer ...
Breaking Medicine Technology:Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
... , , SANTA FE SPRINGS, Calif., ... in the design and manufacturing of superior air cleaning products, ... year,s exclusive Top 10 Products for Parents listing by Parent ... I look for the safest products available for my children," ...
... , , , ... Obama Administration rejected a plan to allow the wholesale reimportation ... take on the drug industry and secure cheaper prescription for ... percent more for drugs than people in Canada, Australia, the ...
Cached Medicine Technology:IQAir HealthPro Plus Selected as a Top 10 Product for Parents 2IQAir HealthPro Plus Selected as a Top 10 Product for Parents 3Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 3
(Date:9/17/2014)... New York, N.Y. (PRWEB) September 17, 2014 ... for fans taking part in the fitness industry’s most ... in Las Vegas, NV. Two fans will each take ... fully loaded with Neon Sport supplements and gear. Fitmark ... booth during the Olympia Expo, September 19-20th. , ...
(Date:9/17/2014)... September 17, 2014 According to ... ), the leading global authority in medical device ... and regeneration market is expected to exceed ... into breast reconstruction, hernia repair, dural repair, vaginal ... and dental soft tissue regeneration. , Approximately ...
(Date:9/17/2014)... Kamut International is pleased to announce ... in Michael Angelo’s new “Made With Organic” ready-made, frozen ... lasagna ready made, frozen meal. Michael Angelo’s products feature ... new products align well with Kamut International’s mission to ... wheat must be grown certified organic. , The new ...
(Date:9/17/2014)... PA (PRWEB) September 17, 2014 ... and increase efficiency. Today, Pharmacy Healthcare Solutions, a ... a web-based analysis and forecasting tool that enables ... maximizing the impact of medications on improved patient ... Reporting uses pharmacy purchase data to identify areas ...
(Date:9/17/2014)... HealthDay Reporter , TUESDAY, ... Americans dying from accidental overdoses of narcotic painkillers jumped ... Tuesday. Deaths from overdoses of drugs such as ... per 100,000 people to 5.4 per 100,000, according ... That means about 3,000 people died in 1999 ...
Breaking Medicine News(10 mins):Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 3Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 2Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 3
... ... for Haiti,s Earthquake Victims, New Campaign Seeks Participants in Healing Service for Chile on ... ... and Master Zhi Gang Sha and the Institute of Soul Healing and Enlightenment, shortly after ...
... ... ... ... ...
... ... ... , ... , , ...
... ... ... ... ...
... of the major cancers in Northeast Thailand. This cancer ... mortality rates. Overexpression of Met, a hepatocyte growth factor ... is correlated with progression of this type of cancer. ... cell scattering, invasion and proliferation. Although a number of ...
... to see the human brain at work, a new generation ... appeal while it is still being designed, according to a ... University. So-called "neuromarketing" takes the tools of modern brain ... somewhat abstract likes and dislikes of customer decision-making. Though ...
Cached Medicine News:Health News:Master Zhi Gang Sha Dedicates Soul Healing Blessings for Humanity Service to Chile's Earthquake Victims 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 3Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 4Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 5Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 2Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 3Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 4Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 2Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 3Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 4Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 5Health News:Different signaling pathways of cholangiocarcinoma 2
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
The most traditional style of instrument, a classical punch shape with the parrot beak upper jaw to aid in the capture of tissue....
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
Medicine Products: